MCMCB Pro
J3396

J3396Injection, verteporfin, 0.1 mg

HCPCSActiveBETOS O1E

J3396 is a HCPCS Level II code for injection, verteporfin, 0.1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J3396 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
150 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
150 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
DME supplier
0 — never payable
MAI 3 — Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J3396

Long descriptor
Injection, verteporfin, 0.1 mg

The official wording. This is what the code means.

Short descriptor
Verteporfin injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2005

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J3396

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J3396 is not quite right, the correct code is very often within a few positions of it.

  • J3385Injection, velaglucerase alfa, 100 units
  • J3386Injection, etuvetidigene autotemcel, per treatment
  • J3387Injection, elivaldogene autotemcel, per treatment
  • J3389Topical administration, prademagene zamikeracel, per treatment
  • J3391Injection, atidarsagene autotemcel, per treatment
  • J3392Injection, exagamglogene autotemcel, per treatment
  • J3393Injection, betibeglogene autotemcel, per treatment
  • J3394Injection, lovotibeglogene autotemcel, per treatment
  • J3397Injection, vestronidase alfa-vjbk, 1 mg
  • J3398Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
  • J3399Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
  • J3400Injection, triflupromazine hcl, up to 20 mgterminated
  • J3401Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
  • J3402Injection, remestemcel-l-rknd, per therapeutic dose
  • J3403Revakinagene taroretcel-lwey, per implant
  • J3404Injection, zopapogene imadenovec-drba suspension, per therapeutic dose

Questions about J3396

What is HCPCS code J3396?

J3396 is a HCPCS Level II code for injection, verteporfin, 0.1 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J3396?

The CMS HCPCS file marks J3396 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J3396 paid under the physician fee schedule?

J3396 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026